LONDON (AFX) - Provexis PLC said it has entered into a long-term collaboration agreement with Unilever PLC to jointly develop a new concentrated format of its patented Fruitflow heart-health technology for application in Unilever's food product portfolio.

Financial details of the deal were not disclosed.

The partners plan to enter into a global licence arrangement for the technology.

Fruitflow is a patented natural extract from tomato which Provexis said has been shown in human trials to reduce the propensity for aberrant blood clotting that is typically associated with cardiovascular disease and which can lead to heart attack or stroke.

In 2005 the market for heart benefit foods was worth 4 bln usd globally, Provexis added.

Considering the growth potential this share has a target of about 8-10p in the medium tern and is a good buy at current levels

As usual, pls do ur own research.

The SP has begun to move steadily up out of its lower recent range perhaps hinting at imminent announcements re the value of the Unilever agreement.....

Some news should be forthcoming soon upside looks promising, bought some today in anticipation.

Hi Halifax,

are you new in, or a patient long termer?

as per charts the stock has broken a resistance level and given a positive signal for the long-term trading range. The stock has broken up through the resistance at p 3.34. This predicts a further rise.

you can expect the share at around atleast 5p within 4 weeks

Bought in this morning with my SMRT preceeds.....this looks like a good story developing. Looking forward to doubling my investment over the coming 6/12months (imho)

More developing news with clarification of two global brands on the table for the juice sector. As per my understanding that Unilever is not looking at the juice sector, these are two new potential partners who are developed enough in their negotiations to make PXS confident in dropping Sirco.

'Provexis is currently in discussions with two major global beverage brand owners
regarding potential license arrangements for Fruitflow(R) in juice and juice
drinks and these companies require extensive, exclusive geographical rights,
which the closure of Sirco(R) will facilitate. The Company hopes that these
discussions will reach a satisfactory conclusion in due course.'

think its still a good time to buy before the confirmation of the deal comes through, which could possibly be within weeks. looks like the talks are in final stage or they would not close sirco. "Global Nomad" as you suggested the deal must me near close to take this step.

,

Charts added... Onwards and upwards !

you can note that the sp has not only gone through the 50 day average but also moved above the 200 day average....

guys any ideas or info on the trade huge volume today

lots of big sells but no impact on SP - good sign,

apparently a couple of papers on friday mentioned expected news re tie up with global drinks company.

going well today... onwards and upwards...on speculation that we must be getting good news soon..

Heard FT have reported a rumour that PXS maybe in talks with Pepsi. that explains the move.

Up on pepsi co rumour!

Maybe, just maybe......bring it on!

http://www.ft.com/cms/s/800abb8a-2e7d-11dc-821c-0000779fd2ac.html

"Provexis was flat at 3.87p in spite of talk the nutrition and health foods group could sign a licensing deal with PepsiCo for Fruitflow, its cholesterol-lowering drink."

FLYING HIGH UP IN SKY !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

LONDON (AFX) - AIM-listed Provexis said it has entered into an exclusive
12-month agreement with an unnamed, global branded food group to jointly develop
and use Provexis' Fruitflow bioactive food ingredient, which has been shown to
combat thrombosis.
The company, which develops scientifically-proven functional and medical
foods, said the agreement will see the two groups jointly developing a
second-generation concentrated format of Fruitflow to increase the scope of its
applications.
Provexis described the agreement as "an important milestone" and noted it
hopes to establish a "long-term, global licensing deal" with the partner food
group within 12 months.
Meanwhile, Provexis also announced the resignation, with immediate effect,
of chief executive Stephen Franklin.
Stephen Moon, up until now the company's commercial director, has been
appointed as Franklin's replacement.
Franklin will continue to work at Provexis as acting director of research
until early 2007, the company said.
newsdesk@afxnews.com

Is this partner PEPSI ? cos this news was out 20 days back, if it is refering to PEPSICO then we are looking at 10P or higher soon.

http://www.advfn.com/news_Provexis_16228014.html

this is very old news..maybe even a year. PXS is already in a provisional agreement with Unilever which is what the above refers to. This is for development of second generation additive which is more usable in a wider range of products. The unilever deal excludes use in juices and drinks as well aas DVT related products. So the Pepsico rumour is an additional tie up which was also expected, the recent statement saying they are in discussions with two ( as well as Unilever) global brands....

From today's timesonline....

Tiddler to watch

Shares in Provexis, the food sciences company, rose 23 per cent to 4p, suggesting that it may be close to signing a licensing deal for its products. Last week Provexis said that it was scrapping its Sirco juice brand to negotiate exclusive rights for licensing partners. Provexiss products may help to deal with blood-clotting and can go into dairy or juice drinks